Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Soni MedicareBOM:539378 +4.99%46 Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus rates BOM:539378 with a GF Score™ of 46/100 and a GF Value™ of ₹30.45 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 575 Healthcare Providers & Services companies, Soni Medicare ranks worse than 173912.87% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Soni Medicare's annualized net income for the quarter that ended in Mar. 2026 was ₹-14.7 Mil. Soni Medicare's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹-15.2 Mil. Therefore, Soni Medicare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was N/A%.
The historical rank and industry rank for Soni Medicare's Return-on-Tangible-Equity or its related term are showing as below:
During the past 12 years, Soni Medicare's highest Return-on-Tangible-Equity was 4.80%. The lowest was -78.47%. And the median was -15.26%.
BOM:539378's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.45 * Ranked among companies with meaningful Return-on-Tangible-Equity only.
Soni Medicare (BOM:539378) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Soni Medicare Return-on-Tangible-Equity Related Terms
Soni Medicare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Soni Medicare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539378 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Soni Medicare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Soni Medicare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Soni Medicare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Soni Medicare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
Soni Medicare (BOM:539378) has a Return-on-Tangible-Equity of 0.00% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Soni Medicare and its competitors. According to the industry distribution chart, Soni Medicare ranks #999999 out of 575 companies in the Healthcare Providers & Services industry.
Is Soni Medicare's Return-on-Tangible-Equity too high?
Soni Medicare's current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Soni Medicare ranks #999999 out of 575 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Soni Medicare has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Soni Medicare's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Soni Medicare ranks #999999 out of 575 companies for Return-on-Tangible-Equity. This places Soni Medicare in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.45, based on 575 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Soni Medicare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Soni Medicare's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Soni Medicare stock overvalued right now?
Based on GuruFocus' analysis, Soni Medicare (BOM:539378) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹30.45, compared to a current price of ₹66.97 — trading 119.9% above its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. Soni Medicare's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Soni Medicare (BOM:539378), the current Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Soni Medicare (BOM:539378) Overvalued in 2026?
Based on GuruFocus' analysis, Soni Medicare stock appears to be overvalued.
The current stock price of ₹66.97 is trading 119.9% above its estimated GF Value™ of ₹30.45.
GuruFocus considers Soni Medicare to be Significantly Overvalued.
Key valuation signals for BOM:539378:
Return-on-Tangible-Equity: 0.00%
GF Value™: ₹30.45 vs. price of ₹66.97 (119.9% above fair value)
No single metric tells the full story. See the BOM:539378 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Soni Medicare Ltd is an India-based company engaged in providing human health services. It provides services like education and courses, health check-ups, patient counseling, outpatient services, inpatient services, emergency care, intensive care unit, dialysis centers, operation theatre, laboratory services, physiotherapy, blood bank, oncology, pharmacies, radiology services, and orthopedic services. The company generates its revenue from providing super specialty and general hospital services.
46GF Score
Get the complete analysis for BOM:539378
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539378 has been successfully added to your 
